Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Hänel M, Kröger N, Sonnenberg S, Bornhäuser M, Krüger W, Kroschinsky F, Hänel A, Metzner B, Birkmann J, Schmid B, Hoffknecht MM, Fiedler F, Ehninger G, Zander AR.
Hänel M, et al. Among authors: kroschinsky f.
Ann Hematol. 2002 Feb;81(2):96-102. doi: 10.1007/s00277-001-0413-8. Epub 2002 Jan 10.
Ann Hematol. 2002.
PMID: 11907790